Zenith Drugs Ltd
NSE: ZENITHDRUG BSE: 92356
₹39.95
(3.90%)
Wed, 08 Apr 2026, 09:24 am
Market Cap653.37M
PE Ratio18.14
Dividend1.31
Company History
2000
- The company was incorporated as Zenith Drugs Private Limited.
2001
- The company started as a manufacturing house for oral and external formulations.
2004
- The company shifted to a Schedule M GMP compliant unit.
- The company started production of liquid orals and ointments.
2007
- The company started manufacturing ORS Powder.
2016
- The company received WHO GMP certification.
2019
- The company's turnover crossed 50 Crores.
2020
- The company's turnover crossed 75 Crores.
2021
- The company received a Certificate of Quality Management System ISO 9001:2015 from Global Grading Certification.
- The company received a certificate of compliance with good manufacturing practices from Liberia Medicines and Health Products Regulatory Authority.
- The company received a subsidy under the Madhya Pradesh MSME Yojna, a grant of 40% of the capital invested in machinery.
2022
- The company was recognized as one of the top 10 MSME Pharmaceutical Manufacturers in Indore by Industry Outlook Magazine.
2023
- The company's turnover crossed 100 Crores.
- The company collaborated with Mr. Kshatriya Valtaprasad Nandkishore for marketing and export of its products.
- The company was converted from a Private Limited Company to a Public Limited Company.
2024
- Zenith Drugs was awarded Tenders issued by the Uttar Pradesh Medical Supplies Corporation Limited.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800